Collaborative Study of a Proposed International Standard for Plasma Fibrinogen Measurement

Summary

There is increased interest in the relationship between plasma fibrinogen levels and the incidence of coronary artery disease. The National Institute for Biological Standards and Control (UK) has completed a study to establish an International Standard for plasma fibrinogen. This study was conducted using a recommended assay procedure to measure the clottable material present in the proposed lyophilised Standard (coded 89/644). Twenty-two laboratories from nine countries took part in the study and analysis of the data allowed the calibration of 89/644 at 2.4 mg/ml clottable protein. Agreement with this figure was established in two laboratories using three or more different assays for plasma fibrinogen. Degradation studies of the proposed plasma fibrinogen Standard suggested that no loss of clottable protein was observed when the lyophilised material was stored at 20° C for 1 year.

The Fibrinogen Sub-Committee of the ISTH (Amsterdam, The Netherlands, June 1991) supported the establishment of 89/644 as an International Standard. This collaborative study will be presented to the Expert Committee on Biological Standardisation of the World Health Organisation at their 1992 session. In the meantime 89/644 will be distributed as the proposed International Standard for plasma fibrinogen measurement containing 2.4 mg/ ml clottable protein.

• REFERENCES

• 1 Rampling MW, Gaffney PJ. Measurement of fibrinogen in plasma. In: Prog Chemical/Fibrinolysis and Thrombosis.. Davidson JF, Samama MM, Desnoyers PC. (eds) Raven Press, New York: 1976. Vol 2: pp 091-105
• 2 Meade TW. Hypercoagulability and ischaemic heart disease. Blood Rev 1987; 1: 2-8
• 3 Furlan M, Felix R, Escher N, Lämmle B. How high is the true fibrinogen content of fibrinogen standards? Thromb Res. 1989; 56: 583-592
• 4 Campbell PJ. International biological standards and reference preparations. 1. Preparation and presentation of materials to serve as standards and reference preparations. J Biol Stand 1974; 2: 249-258
• 5 Jacobsson K. Studies in the determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest 1955; 7, Suppl 14: 01-54
• 6 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1959; 17: 237-246
• 7 Ratnoff O, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med 1951; 37: 316-320
• 8 Hoegee-de Nobel E, Voskuilen M, Briët E, Brommer EJP, Nieuwenhuizen W. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations. Thromb Haemostas 1988; 60: 415-418
• 9 Carr ME, Hermans J. Size and density of fibrin fibres from turbidity. Macromolecules 1978; 11: 46-50
• 10 Kirkwood TBL. Design and analysis of accelerated degradation tests for the stability of biological standards III, principles of design. J Biol Stand 1984; 12: 215-224
• 11 Gaffney PJ. Structure of fibrinogen and degradation products of fibrinogen and fibrin. Br Med Bull 1977; 33: 245-252
• 12 Pring JB, Gaffney PJ. Fibrin formation. Influence of various components of coagulation and fibrinolysis on clot structure. Thromb Haemostas 1991; 65: 904 (Abstract)